The ambulatory blood pressure monitoring devices market size has grown rapidly in recent years. It will grow from $1.15 billion in 2025 to $1.29 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to limited access to ambulatory monitoring devices, reliance on manual blood pressure measurements, increasing prevalence of hypertension, growing hospital-based cardiovascular monitoring, awareness of nocturnal and white-coat hypertension.
The ambulatory blood pressure monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to technological advancements in wearable and smartphone-integrated devices, rising homecare adoption, increasing demand for automated abpm devices, expansion of remote patient monitoring solutions, integration with digital health platforms and telemedicine. Major trends in the forecast period include rising adoption of home-based blood pressure monitoring, integration of wearable and smartphone-enabled abpm devices, growing awareness of white-coat and nocturnal hypertension, expansion of preoperative and postoperative cardiovascular monitoring, increasing focus on continuous and remote patient monitoring.
The rising prevalence of hypertension is expected to drive the growth of the ambulatory blood pressure monitoring devices market moving forward. Hypertension is a condition marked by consistently elevated blood pressure levels in the arteries. Its increasing occurrence is fueled by factors such as unhealthy diets, sedentary lifestyles, and rising obesity rates. Ambulatory blood pressure monitoring devices assist in managing hypertension by providing continuous and accurate blood pressure measurements during daily activities and sleep, allowing for improved diagnosis and personalized treatment. For example, in September 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that hypertension affects one in three adults globally (approximately 1.3 billion people), and increasing effective treatment coverage to 50% by 2025 could prevent 76 million deaths by 2050. Thus, the growing prevalence of hypertension is anticipated to boost the ambulatory blood pressure monitoring devices market.
Major companies operating in the ambulatory surgical pressure monitoring devices market are focusing on technological advancements such as point-of-care devices to improve real-time monitoring accuracy, enhance patient comfort, and enable faster clinical decision-making. A point-of-care device is a medical tool used at or near the patient’s location to deliver immediate diagnostic or monitoring results without reliance on centralized laboratory facilities. For example, in October 2024, Withings, a France-based digital health technology company, introduced the BPM Pro 2, an advanced remote blood pressure monitoring device designed to support real-world cardiovascular assessment. The device provides accurate blood pressure readings and includes built-in cellular, Wi-Fi, and Bluetooth connectivity, allowing real-time data transmission between patients and healthcare providers without requiring a smartphone. It also features an integrated Patient Insights tool that captures symptom and lifestyle information after each measurement, enabling clinicians to make faster and more informed decisions. Additionally, on-device guidance and retake prompts help ensure measurement reliability, while its user-friendly design improves comfort and promotes consistent monitoring for better hypertension management outside clinical settings.
In May 2025, Withings Health Solutions, a France-based provider of digital health devices and remote patient monitoring solutions, partnered with Babyscripts to strengthen remote ambulatory blood pressure monitoring. Through this collaboration, the companies aim to enhance early detection and management of hypertensive disorders during pregnancy by using real-time data and patient-centered monitoring, with the goal of reducing maternal morbidity and mortality. Babyscripts is a U.S.-based company that delivers virtual maternity care programs integrating digital devices and patient monitoring to support personalized prenatal care.
Major companies operating in the ambulatory blood pressure monitoring devices market are Koninklijke Philips NV, GE Healthcare Technologies Inc, Omron Healthcare Co Ltd, Hill Rom Holdings Inc, Halma plc, Spacelabs Healthcare Inc, Schiller Holding AG, Withings SA, Contec Medical Systems Co Ltd, BPL Medical Technologies Private Limited, Microlife AG, SunTech Medical Inc, Rossmax International Ltd, Rudolf Riester GmbH, iHealth Labs Inc, American Diagnostic Corporation, Bosch and Sohn GmbH and Co KG, A and D Medical, Welch Allyn Hill Rom, CardieX Limited.
North America was the largest region in the ambulatory blood pressure monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ambulatory blood pressure monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ambulatory blood pressure monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ambulatory blood pressure monitoring devices market by increasing the cost of imported electronic components, sensors, and cuffs used in ABPM devices. Segments like Bluetooth-enabled, smartphone-integrated, and wearable devices are most impacted, particularly in Asia-Pacific regions such as China and India. These tariffs have raised production costs and slowed supply chain operations. However, they have also encouraged local manufacturing, investment in domestic production capabilities, and innovation in cost-effective device designs.
The ambulatory blood pressure monitoring devices market research report is one of a series of new reports that provides ambulatory blood pressure monitoring devices market statistics, including ambulatory blood pressure monitoring devices industry global market size, regional shares, competitors with a ambulatory blood pressure monitoring devices market share, detailed ambulatory blood pressure monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the ambulatory blood pressure monitoring devices industry. This ambulatory blood pressure monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ambulatory blood pressure monitoring (ABPM) devices are medical instruments designed to continuously measure blood pressure over a 24-hour period while the patient engages in their regular daily activities. These devices generally include a cuff and a digital recorder worn on the body. They offer more accurate and comprehensive blood pressure data compared to single-point measurements. ABPM is particularly valuable for diagnosing conditions such as white-coat hypertension and nocturnal hypertension.
The main types of ambulatory blood pressure monitoring devices include automatic ABPM devices, manual ABPM devices, and specialized ABPM devices. Automatic ABPM devices automatically record blood pressure at set intervals throughout the 24-hour period without the need for manual input. Device categories include ambulatory blood pressure monitors, home blood pressure monitors, hospital blood pressure monitors, wearable blood pressure monitors, and finger blood pressure monitors. These devices are used in hypertension management, cardiovascular disease monitoring, preoperative assessment, and postoperative monitoring. They are distributed through various channels such as direct sales, online retail, third-party distributors, and pharmacies. The primary end users include hospitals, homecare providers, prescription users, and over-the-counter (OTC) consumers.
The ambulatory blood pressure monitoring devices market consists of revenues earned by entities by providing services such as tele monitoring services, clinical research support services, integration and it support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ambulatory blood pressure monitoring (abpm) devices market includes sales of bluetooth-enabled abpm devices, programmable abpm devices, and digital abpm devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ambulatory blood pressure monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to technological advancements in wearable and smartphone-integrated devices, rising homecare adoption, increasing demand for automated abpm devices, expansion of remote patient monitoring solutions, integration with digital health platforms and telemedicine. Major trends in the forecast period include rising adoption of home-based blood pressure monitoring, integration of wearable and smartphone-enabled abpm devices, growing awareness of white-coat and nocturnal hypertension, expansion of preoperative and postoperative cardiovascular monitoring, increasing focus on continuous and remote patient monitoring.
The rising prevalence of hypertension is expected to drive the growth of the ambulatory blood pressure monitoring devices market moving forward. Hypertension is a condition marked by consistently elevated blood pressure levels in the arteries. Its increasing occurrence is fueled by factors such as unhealthy diets, sedentary lifestyles, and rising obesity rates. Ambulatory blood pressure monitoring devices assist in managing hypertension by providing continuous and accurate blood pressure measurements during daily activities and sleep, allowing for improved diagnosis and personalized treatment. For example, in September 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that hypertension affects one in three adults globally (approximately 1.3 billion people), and increasing effective treatment coverage to 50% by 2025 could prevent 76 million deaths by 2050. Thus, the growing prevalence of hypertension is anticipated to boost the ambulatory blood pressure monitoring devices market.
Major companies operating in the ambulatory surgical pressure monitoring devices market are focusing on technological advancements such as point-of-care devices to improve real-time monitoring accuracy, enhance patient comfort, and enable faster clinical decision-making. A point-of-care device is a medical tool used at or near the patient’s location to deliver immediate diagnostic or monitoring results without reliance on centralized laboratory facilities. For example, in October 2024, Withings, a France-based digital health technology company, introduced the BPM Pro 2, an advanced remote blood pressure monitoring device designed to support real-world cardiovascular assessment. The device provides accurate blood pressure readings and includes built-in cellular, Wi-Fi, and Bluetooth connectivity, allowing real-time data transmission between patients and healthcare providers without requiring a smartphone. It also features an integrated Patient Insights tool that captures symptom and lifestyle information after each measurement, enabling clinicians to make faster and more informed decisions. Additionally, on-device guidance and retake prompts help ensure measurement reliability, while its user-friendly design improves comfort and promotes consistent monitoring for better hypertension management outside clinical settings.
In May 2025, Withings Health Solutions, a France-based provider of digital health devices and remote patient monitoring solutions, partnered with Babyscripts to strengthen remote ambulatory blood pressure monitoring. Through this collaboration, the companies aim to enhance early detection and management of hypertensive disorders during pregnancy by using real-time data and patient-centered monitoring, with the goal of reducing maternal morbidity and mortality. Babyscripts is a U.S.-based company that delivers virtual maternity care programs integrating digital devices and patient monitoring to support personalized prenatal care.
Major companies operating in the ambulatory blood pressure monitoring devices market are Koninklijke Philips NV, GE Healthcare Technologies Inc, Omron Healthcare Co Ltd, Hill Rom Holdings Inc, Halma plc, Spacelabs Healthcare Inc, Schiller Holding AG, Withings SA, Contec Medical Systems Co Ltd, BPL Medical Technologies Private Limited, Microlife AG, SunTech Medical Inc, Rossmax International Ltd, Rudolf Riester GmbH, iHealth Labs Inc, American Diagnostic Corporation, Bosch and Sohn GmbH and Co KG, A and D Medical, Welch Allyn Hill Rom, CardieX Limited.
North America was the largest region in the ambulatory blood pressure monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ambulatory blood pressure monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ambulatory blood pressure monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ambulatory blood pressure monitoring devices market by increasing the cost of imported electronic components, sensors, and cuffs used in ABPM devices. Segments like Bluetooth-enabled, smartphone-integrated, and wearable devices are most impacted, particularly in Asia-Pacific regions such as China and India. These tariffs have raised production costs and slowed supply chain operations. However, they have also encouraged local manufacturing, investment in domestic production capabilities, and innovation in cost-effective device designs.
The ambulatory blood pressure monitoring devices market research report is one of a series of new reports that provides ambulatory blood pressure monitoring devices market statistics, including ambulatory blood pressure monitoring devices industry global market size, regional shares, competitors with a ambulatory blood pressure monitoring devices market share, detailed ambulatory blood pressure monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the ambulatory blood pressure monitoring devices industry. This ambulatory blood pressure monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ambulatory blood pressure monitoring (ABPM) devices are medical instruments designed to continuously measure blood pressure over a 24-hour period while the patient engages in their regular daily activities. These devices generally include a cuff and a digital recorder worn on the body. They offer more accurate and comprehensive blood pressure data compared to single-point measurements. ABPM is particularly valuable for diagnosing conditions such as white-coat hypertension and nocturnal hypertension.
The main types of ambulatory blood pressure monitoring devices include automatic ABPM devices, manual ABPM devices, and specialized ABPM devices. Automatic ABPM devices automatically record blood pressure at set intervals throughout the 24-hour period without the need for manual input. Device categories include ambulatory blood pressure monitors, home blood pressure monitors, hospital blood pressure monitors, wearable blood pressure monitors, and finger blood pressure monitors. These devices are used in hypertension management, cardiovascular disease monitoring, preoperative assessment, and postoperative monitoring. They are distributed through various channels such as direct sales, online retail, third-party distributors, and pharmacies. The primary end users include hospitals, homecare providers, prescription users, and over-the-counter (OTC) consumers.
The ambulatory blood pressure monitoring devices market consists of revenues earned by entities by providing services such as tele monitoring services, clinical research support services, integration and it support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ambulatory blood pressure monitoring (abpm) devices market includes sales of bluetooth-enabled abpm devices, programmable abpm devices, and digital abpm devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ambulatory Blood Pressure Monitoring Devices Market Characteristics
3. Ambulatory Blood Pressure Monitoring Devices Market Supply Chain Analysis
4. Global Ambulatory Blood Pressure Monitoring Devices Market Trends and Strategies
5. Ambulatory Blood Pressure Monitoring Devices Market Analysis of End Use Industries
7. Global Ambulatory Blood Pressure Monitoring Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ambulatory Blood Pressure Monitoring Devices Total Addressable Market (TAM) Analysis for the Market
9. Ambulatory Blood Pressure Monitoring Devices Market Segmentation
10. Ambulatory Blood Pressure Monitoring Devices Market Regional and Country Analysis
11. Asia-Pacific Ambulatory Blood Pressure Monitoring Devices Market
12. China Ambulatory Blood Pressure Monitoring Devices Market
13. India Ambulatory Blood Pressure Monitoring Devices Market
14. Japan Ambulatory Blood Pressure Monitoring Devices Market
15. Australia Ambulatory Blood Pressure Monitoring Devices Market
16. Indonesia Ambulatory Blood Pressure Monitoring Devices Market
17. South Korea Ambulatory Blood Pressure Monitoring Devices Market
18. Taiwan Ambulatory Blood Pressure Monitoring Devices Market
19. South East Asia Ambulatory Blood Pressure Monitoring Devices Market
20. Western Europe Ambulatory Blood Pressure Monitoring Devices Market
21. UK Ambulatory Blood Pressure Monitoring Devices Market
22. Germany Ambulatory Blood Pressure Monitoring Devices Market
23. France Ambulatory Blood Pressure Monitoring Devices Market
24. Italy Ambulatory Blood Pressure Monitoring Devices Market
25. Spain Ambulatory Blood Pressure Monitoring Devices Market
26. Eastern Europe Ambulatory Blood Pressure Monitoring Devices Market
27. Russia Ambulatory Blood Pressure Monitoring Devices Market
28. North America Ambulatory Blood Pressure Monitoring Devices Market
29. USA Ambulatory Blood Pressure Monitoring Devices Market
30. Canada Ambulatory Blood Pressure Monitoring Devices Market
31. South America Ambulatory Blood Pressure Monitoring Devices Market
32. Brazil Ambulatory Blood Pressure Monitoring Devices Market
33. Middle East Ambulatory Blood Pressure Monitoring Devices Market
34. Africa Ambulatory Blood Pressure Monitoring Devices Market
36. Ambulatory Blood Pressure Monitoring Devices Market Competitive Landscape and Company Profiles
37. Ambulatory Blood Pressure Monitoring Devices Market Other Major and Innovative Companies
40. Ambulatory Blood Pressure Monitoring Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Ambulatory Blood Pressure Monitoring Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ambulatory blood pressure monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ambulatory blood pressure monitoring devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ambulatory blood pressure monitoring devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Automatic ABPM Devices; Manual ABPM Devices; Specialised ABPM Devices2) By Device Type: Ambulatory Blood Pressure Monitor; Home Blood Pressure Monitor; Hospital Blood Pressure Monitor; Wearable Blood Pressure Monitor
3) By Applications: Hypertension Management; Cardiovascular Disease Monitoring; Preoperative Assessment; Postoperative Monitoring
4) By Distribution Channel: Direct Sales; Online Retail; Third-Party Distributors; Pharmacies
5) By End Use: Hospitals; Homecare; Prescription; OTC
Subsegments:
1) By Automatic ABPM Devices: Upper Arm Automatic ABPM Devices; Wrist-Worn Automatic ABPM Devices; Bluetooth-Enabled Automatic ABPM Devices; Smartphone-Integrated ABPM Devices2) By Manual ABPM Devices: Aneroid Manual ABPM Devices; Mercury-Based Manual ABPM Devices; Digital Readout Manual Devices (Semi-Automatic)
3) By Specialised ABPM Devices: Pediatric ABPM Devices; Geriatric ABPM Devices; Nocturnal ABPM Devices; Wearable Patch-Based ABPM Devices
Companies Mentioned: Koninklijke Philips NV; GE Healthcare Technologies Inc; Omron Healthcare Co Ltd; Hill Rom Holdings Inc; Halma plc; Spacelabs Healthcare Inc; Schiller Holding AG; Withings SA; Contec Medical Systems Co Ltd; BPL Medical Technologies Private Limited; Microlife AG; SunTech Medical Inc; Rossmax International Ltd; Rudolf Riester GmbH; iHealth Labs Inc; American Diagnostic Corporation; Bosch and Sohn GmbH and Co KG; A and D Medical; Welch Allyn Hill Rom; CardieX Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ambulatory Blood Pressure Monitoring Devices market report include:- Koninklijke Philips NV
- GE Healthcare Technologies Inc
- Omron Healthcare Co Ltd
- Hill Rom Holdings Inc
- Halma plc
- Spacelabs Healthcare Inc
- Schiller Holding AG
- Withings SA
- Contec Medical Systems Co Ltd
- BPL Medical Technologies Private Limited
- Microlife AG
- SunTech Medical Inc
- Rossmax International Ltd
- Rudolf Riester GmbH
- iHealth Labs Inc
- American Diagnostic Corporation
- Bosch and Sohn GmbH and Co KG
- A and D Medical
- Welch Allyn Hill Rom
- CardieX Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.29 Billion |
| Forecasted Market Value ( USD | $ 1.98 Billion |
| Compound Annual Growth Rate | 11.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
